Differential Effects of Fingolimod and Natalizumab on B Cell Repertoires in Multiple Sclerosis Patients
Markus C. Kowarik, David P. Astling, Gildas Lepennetier, Alanna Ritchie, Bernhard Hemmer, Greg Owens, Jeffrey L. Bennett
Topics & Concepts
FingolimodNatalizumabMultiple sclerosisMedicineImmunologyB cellAntibodyMultiple Sclerosis Research StudiesT-cell and B-cell ImmunologySphingolipid Metabolism and Signaling